What is Northland Capmk's Estimate for AMPX FY2025 Earnings?

Key Points

• Northland Capmk cut its FY2025 EPS estimate for Amprius to ($0.25) from ($0.21), compared with a MarketBeat consensus full-year loss of ($0.45) per share.
• Amprius recently beat the quarter's estimates—reporting ($0.03) EPS vs. a ($0.06) consensus and $21.43M revenue (vs. $16.45M)—but remains unprofitable with negative ROE/net margin, has seen insider selling, and carries a consensus analyst rating of "Moderate Buy" with a $14.57 target.

Amprius Technologies, Inc. (NYSE:AMPX - Free Report) - Northland Capmk reduced their FY2025 earnings estimates for shares of Amprius Technologies in a note issued to investors on Thursday, January 8th. Northland Capmk analyst E. Jackson now forecasts that the company will earn ($0.25) per share for the year, down from their prior forecast of ($0.21). The consensus estimate for Amprius Technologies' current full-year earnings is ($0.45) per share.

Amprius Technologies (NYSE:AMPX - Get Free Report) last issued its earnings results on Thursday, November 6th. The company reported ($0.03) EPS for the quarter, beating analysts' consensus estimates of ($0.06) by $0.03. Amprius Technologies had a negative return on equity of 38.85% and a negative net margin of 53.16%.The business had revenue of $21.43 million during the quarter, compared to analyst estimates of $16.45 million.

Other equities analysts have also recently issued reports about the company. Oppenheimer reiterated an "outperform" rating and issued a $17.00 target price on shares of Amprius Technologies in a report on Tuesday, December 23rd. Northland Securities set a $20.00 price objective on shares of Amprius Technologies in a report on Tuesday, October 7th. Roth Capital set a $14.00 price objective on shares of Amprius Technologies and gave the company a "buy" rating in a research note on Wednesday, October 22nd. Weiss Ratings reiterated a "sell (e+)" rating on shares of Amprius Technologies in a report on Wednesday, October 8th. Finally, Cantor Fitzgerald boosted their target price on shares of Amprius Technologies from $12.00 to $16.00 and gave the stock an "overweight" rating in a research report on Friday, November 7th. Seven equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $14.57.

Amprius Technologies Stock Performance

Shares of Amprius Technologies stock opened at $9.48 on Monday. The stock has a market capitalization of $1.24 billion, a PE ratio of -36.44 and a beta of 3.04. Amprius Technologies has a 52 week low of $1.70 and a 52 week high of $16.03. The stock has a 50 day moving average price of $10.45 and a two-hundred day moving average price of $9.44.

Insider Buying and Selling at Amprius Technologies

In other Amprius Technologies news, CEO Kang Sun sold 68,655 shares of the company's stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $10.08, for a total value of $692,042.40. Following the completion of the sale, the chief executive officer directly owned 1,403,651 shares of the company's stock, valued at approximately $14,148,802.08. This represents a 4.66% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CTO Constantin Ionel Stefan sold 198,255 shares of the stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $10.51, for a total transaction of $2,083,660.05. Following the completion of the sale, the chief technology officer owned 748,696 shares of the company's stock, valued at approximately $7,868,794.96. This trade represents a 20.94% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 1,291,934 shares of company stock valued at $13,627,944. Company insiders own 12.80% of the company's stock.

Institutional Trading of Amprius Technologies

Large investors have recently added to or reduced their stakes in the stock. Voloridge Investment Management LLC purchased a new position in Amprius Technologies in the third quarter valued at about $19,737,000. BNP Paribas Financial Markets increased its stake in shares of Amprius Technologies by 1,117.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,943,905 shares of the company's stock worth $20,450,000 after purchasing an additional 1,784,291 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Amprius Technologies by 37.0% in the 3rd quarter. Vanguard Group Inc. now owns 6,512,620 shares of the company's stock worth $68,513,000 after purchasing an additional 1,757,395 shares during the period. Invesco Ltd. lifted its stake in Amprius Technologies by 113.3% in the third quarter. Invesco Ltd. now owns 2,379,384 shares of the company's stock valued at $25,031,000 after purchasing an additional 1,263,846 shares during the last quarter. Finally, Stephens Investment Management Group LLC bought a new position in Amprius Technologies during the third quarter valued at $11,392,000. Hedge funds and other institutional investors own 5.04% of the company's stock.

About Amprius Technologies

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.